Fluidigm Corporation develops, manufactures, and markets life science systems based on integrated fluidic circuits. Organized around integrated fluidic circuits (IFCs) for analysis and synthesis of biomolecules in nano- and pico-volume environments. products include Access Array system, a sample preparation system; BioMark system for genetic analysis; EP1 system for genetic analysis enables SNP genotyping and end point digital PCR research through integrated fluidic circuits; TOPAZ system for screen-to-beam protein crystallization; Dynamic Array integrated fluidic circuit, a reusable bio-chip for the SNP genotyping market; and chips and kits. Fluidigm Corporation was formerly known as Mycometrix Corporation, changing its name to Fluidigm Corporation in June 2001.
